These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2765673)

  • 1. Change of deformability and Heinz body formation in G6PD-deficient erythrocytes treated with 5-hydroxy-6-desmethylprimaquine.
    Thompson SF; Fraser IM; Strother A; Bull BS
    Blood Cells; 1989; 15(2):443-52; discussion 453-4. PubMed ID: 2765673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte membrane ATPase activity of G6PD-deficient individuals and the effect of primaquine metabolite(s) on membrane ATPase enzymes.
    Akoğlu T; Ozdoğu H; Erdoğan R; Ozer FL
    J Trop Med Hyg; 1984 Oct; 87(5):219-24. PubMed ID: 6152296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Formate incubation of red blood cells from glucose-6-phosphate-dehydrogenase-deficient patients].
    Grieger M; Schippel W; Siems W; Leppin K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):704-15. PubMed ID: 6198254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.
    Ganesan S; Chaurasiya ND; Sahu R; Walker LA; Tekwani BL
    Toxicology; 2012 Mar; 294(1):54-60. PubMed ID: 22330256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced susceptibility of erythrocytes deficient in glucose-6-phosphate dehydrogenase to alloxan/glutathione-induced decrease in red cell deformability.
    Liu TZ; Lin TF; Hung IJ; Wei JS; Chiu DT
    Life Sci; 1994; 55(3):PL55-60. PubMed ID: 8007756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine.
    Fletcher KA; Barton PF; Kelly JA
    Biochem Pharmacol; 1988 Jul; 37(13):2683-90. PubMed ID: 2839199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
    Wang YM; Patterson JH; Van Eys J
    J Clin Invest; 1971 Jul; 50(7):1421-8. PubMed ID: 4397414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in red blood cell membrane structure in G6PD deficiency: an atomic force microscopy study.
    Tang J; Jiang C; Xiao X; Fang Z; Li L; Han L; Mei A; Feng Y; Guo Y; Li H; Jiang W
    Clin Chim Acta; 2015 Apr; 444():264-70. PubMed ID: 25748035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
    Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between the enzyme activity, lipid peroxidation and red blood cells deformability in hemizygous and heterozygous glucose-6-phosphate dehydrogenase deficient individuals.
    Gurbuz N; Yalcin O; Aksu TA; Baskurt OK
    Clin Hemorheol Microcirc; 2004; 31(3):235-42. PubMed ID: 15322329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metabolites of primaquine and acetanilid on normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
    Fraser IM; Vesell ES
    J Pharmacol Exp Ther; 1968 Jul; 162(1):155-65. PubMed ID: 5656594
    [No Abstract]   [Full Text] [Related]  

  • 12. Relation between reduced glutathione content and Heinz body formation in sheep erythrocytes.
    Goto I; Agar NS; Maede Y
    Am J Vet Res; 1993 Apr; 54(4):622-6. PubMed ID: 8484585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of decreased erythrocyte deformability and survival in glucose 6-phosphate dehydrogenase mutants.
    Flynn TP; Johnson GJ; Allen DW
    Prog Clin Biol Res; 1981; 56():231-49. PubMed ID: 7330011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative activity of hydroxylated primaquine analogs. Non-toxicity to glucose-6-phosphate dehydrogenase-deficient human red blood cells in vitro.
    Baird JK; Davidson DE; Decker-Jackson JE
    Biochem Pharmacol; 1986 Apr; 35(7):1091-8. PubMed ID: 3754445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METHEMOGLOBINEMIA AND HEINZ BODY HEMOLYTIC ANEMIA DUE TO PHENAZOPYRIDINE HYDROCHLORIDE.
    GREENBERG MS; WONG H
    N Engl J Med; 1964 Aug; 271():431-5. PubMed ID: 14171812
    [No Abstract]   [Full Text] [Related]  

  • 16. [METHEMOGLOBINEMIA, HEMOLYSIS AND FORMATION OF HEINZ BODIES IN THE ERYTHROCYTES].
    PALEK J
    Lek Veda Zahr; 1964 Jan; 1():1-10. PubMed ID: 14130762
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
    Ali NA; al-Naama LM; Khalid LO
    East Mediterr Health J; 1999 May; 5(3):457-64. PubMed ID: 10793824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
    Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited, non-spherocytic haemolysis due to deficiency of glucose-6-phosphate dehydrogenase.
    Ronquist G; Theodorsson E
    Scand J Clin Lab Invest; 2007; 67(1):105-11. PubMed ID: 17365988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
    Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.